Beruflich Dokumente
Kultur Dokumente
December, 2015
CURRENT POSITIONS
2006 - Present:
(Tenure Affiliation)
Professor of Immunology
Faculty of Science, Tanta University, Egypt
Tel:
+20-040 334-4352 (work)
+20-01274272624 (mobile)
FAX: +20-040 335-0804
E-mail: mohamed.labib@science.tanta.edu.eg
cecr@unv@tanta.edu.eg
8/2014 - Present
6/2013 Present
6/2013 Present
PAST POSITIONS
Visiting Professer, Department of Microbiology and Immunology
Medical University of South Carolina, Charleston, SC, USA
(+1) 843-327 6156
6/2001-9/2010
Assistant Professer
Surgery Department and Hollings Cancer Center
Medical University of South Carolina, Charleston, SC, USA
(+1) 843-792-7576
6/2010 6/2013
6/2010-6/2012
Page
9/2014 12/2014
http://www.tanta.edu.eg/en/
Curriculum Vitae
December, 2015
http://www.tanta.edu.eg/en/
Page
Submitted
1. Elmaadawi, iman; Ibrahim, Zeinab; abdou, said; el attar, yasmina; Youssef, Amira ; Shamloula, Maha,
Gabr, Hala, Taha, Atef, El Afandy, Mohamed ; Mohamed L. Salem. Stem cell therapy as a novel
therapeutic intervention for resistant cases of alopecia. J Dermatological Treatment, 2016.
2. *Mohamed L. Salem, Abdel-Aziz A. Zidan, Abdel Raouf Abou Al-Azm, Hasan Albate, Maha
Aldemelaawy, Mohamed Attia, Mohamed Abo Senna: High numbers of myeloid-derived suppressor
cells associates with low levels of dendritic and T cells in Egyptian patients with chronic HCV
infection who failed IFN- therapy. J Exp Clin Immunol, 2015.
3. *Mohamed L. Salem, Mark Rubenstein and David J. Cole: The toll-like receptor 3 agonist
polyinosinic-cytidylic acid (poly(I:C) targets natural killer cells with NK1.1+CD11b+CD11c+B220+Ly6Gphenotype. World J Gastroentrology, 2016.
Original Article
*, Corresponding authors
In Preparation
1. *Mohamed L. Salem, Mohamed Basyony, Afaf M. ElAtrash and Asmaa A. Salama. The importance of
microenvironment in adoptive cell therapy in young and old tumor bearing mice. In Preparation.
2. Mohamed L. Salem, Mohamed Nassef, Soha Okba, Ibrahim Eissa: Combination of dendritic cellbased vaccine and systemic chemotherapy induced anti-tumor response against murine breast
cancer. In Preparation.
3. Mohamed L. Salem, Nanis Gamal Allam, Hassan Elbataa, Maii Moustafa Nabieh. Antiviral,
Antibacterial and immunomodulatory effects of lactobacillus acidophilus and bifidobacteria in
patients with chronic hepatitis C HCV. In Preparation.
1. Mohamed L. Salem, Eman Maher, Nehal EL-Mashed, Azza El-Amir, Noha A. Sabry. Assessment
health locus of control and generalized expectancies locus of control among University students. In
Preparation.
2. *Mohamed L. Salem, Soha Okba, Mohamed Nassef, Abdel-Aziz Zidan, David J. Cole and John
N. Vournakis. Using poly-N-acetyl glucosamine gel matrix as a novel non-viral delivery approach
for DNA-based vaccination. In Preparation.
3. Mohamed L. Salem, Abdel-Aziz Zidane, Guillermo Rivell, Marcela Diaz-Montero, Osama Naga, David
Cole. In vitro conditioning of antigen-reactive CD8+ T cells with toll-like receptor agonists enhances
their expansion in vivo. In Preparation.
4. * Mohamed L Salem, Nahla M. Shoukry, Wafaa K. Teleb, Mohamed M. Abdel Daim, Mohamed A.
Abdel-Rahman. Evaluation of analgesic, antipyretic and anti-inflammatory effects of the Egyptian
scorpion venom Androctonus amoreuxi. In Preparation.
5. Nahla M. Shoukry, Mohamed L Salem, Wafaa K. Teleb, Mohamed M. Abdel Daim, Mohamed A.
Abdel-Rahman. Potential anti-cancer activities of the Egyptian scorpion venom androctonus
amoreuxi in an Ehrlich ascetic animal model. In Preparation.
6. Nageh Elmahdy, Mohamed L Salem and Sherin Hamed. Therapeutic potential of human umbilical
cord mononuclear cells and mice Bone marrow cells against liver fibrosis in mice. In Preparation.
7. Afrah F. Salama, Mohamed L Salem, Kamal Ali Fathi Shalabi,, Amro Elsherbeny Mohamed.
Evaluation the Ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on
cisplatin-induced toxicity in Tumor-bearing mice. In Preparation.
Curriculum Vitae
December, 2015
http://www.tanta.edu.eg/en/
Page
Published
5. *Mohamed L. Salem, Tarek Mostafa and Ibrahim Eissa: Dendritic cells generated from tumor
bearing mice uniquely restore different leukocyte subpopulations in chemotherapy treated tumor
bearing mice. Clinical Cancer Investigation Journal, In Press, 2016.
6. *Mohamed L Salem, Samar Ezzat, Afaf Al-Atrash and Duaa Samy. Cisplatin enhances the differential
effects of tumor burden on the expression of micro RNA 146a and 155 in spleen and cancer cells in
an experimental tumor model. J Solid Tumors, 2016, In Press.
7. *Mohamed L . Salem, Kadry A. EL-Bakry, Nahed A. Omer and Eman H. Moubark. Treatment with
bone marrow products accelerates recovery from chemotherapy associated leukopenia and liver
injury in tumor bearing mice. Egypt. J. Exp. Biol. (Zool.), 11(2): 201 211 (2015)
8. Nageh El-Mahdy, Mohamed L. Salem, El-Sayad M, El-Desouky KI, Nesma Zaghow. Bone marrow
mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced
myocardial infarction in rats. J Immunotoxicol. 2015 Nov 25:1-10.
9. Mohamed L Salem, SGRA Salam, M Nassef, S Hammad, R El Adl. Immunoenhancing properties of
the anti-tumor effects of adoptively transferred T cells with chemotherapeutic cyclophosphamide by
co-administration of bone marrow cells. The Journal of Basic & Applied Zoology, 2015, 72, 96-103.
10. DA Ghareeb, Mohamed L Salem, N El-Desouky, IH Mohamed. Concomitant treatment with betaglucan and G-CSF ameliorates altered biochemical indices after cyclophosphamide-induced
leukopenia in mice. Biotechnology & Biotechnological Equipment 2015: 29 (5), 970-976
11. Mohamed L Salem, MR El-Shanshory, RE El-Den El-Naggar, SH Abdou, MA Attia, Reduction in the
numbers of CD33+ myeloid population in Egyptian children with B-linage acute lymphoblastic
leukemia and its recovery after induction of chemotherapy. Clinical Cancer Investigation Journal
2015: 4 (5), 627-632.
12. Mohamed L Salem, MR El-Shanshory, NI El-Desouki, SH Abdou, MA Attia. Children with acute
lymphoblastic leukemia show high numbers of CD4+ and CD8+ T-cells which are reduced by
conventional chemotherapy. Clinical Cancer Investigation Journal 2015: 4 (5), 603-609.
13. Mohamed L Salem. Increases in the numbers of myeloid-derived suppressor cells in Egyptian
children with acute lymphoid leukemia. Cancer Research 75 (15 Supplement), 1297-1297.
14. K Andrijauskaite, S Suriano, CA Cloud, M Li, P Kesarwani, LS Stefanik, Mohamed L Salem et al.,. IL-12
conditioning improves retrovirally mediated transduction efficiency of CD8 plus; T cells. Cancer gene
therapy, 2015: 22 (7), 360-367.
15. Enas Abdul-Baki, Mohamed L Salem, MA Mansour, SM Abdou, AAA Zidan. Influence of granulocyte
colony stimulating factor treatment on physiological indices in Wistar rats. Clinical Cancer
Investigation Journal 205: 4 (4), 525.
16. Mohamed L Salem, ZI Attia, SM Galal. Acute inflammation induces immunomodulatory effects on
myeloid cells associated with anti-tumor responses in a tumor mouse model. Journal of Advanced
Research. Available online 19 June 2015
17. NE El-Ashmawy, EA El-Zamarany, Mohamed L Salem, HA El-Bahraw. In vitro and in vivo studies of
the immunomodulatory effect of Echinacea purpurea on dendritic cells. Journal of Genetic
Engineering and Biotechnology. Available online 8 June 2015.
4. *Mohamed L Salem, Mohamed Nassef, Soha Gomaa; Mark Roubstein and David Cole. Effect of
timing of G-CSF administration following cyclophosphamide-induced leukopenia on the host
immune cell recovery and CD8+ T cell responses to prime-boost vaccination. Journal of
immunotoxicology, 2015.
Curriculum Vitae
December, 2015
http://www.tanta.edu.eg/en/
Page
24. Mohamed Basyony, Afaf M. ElAtrash, Asmaa A. Salama, Mohamed L. Salem. Treatment with white
button mushroom extract enhanced the anti-tumor effects and lowered the toxicity of
chemotherapy in a tumor mouse model. Egypt. J. zoology, 2014: (61): 1-14.
25. *Mohamed L. Salem. Shaimaa Talat Ahmed El-Barbary. Immunomodulatory effect of single and
combinatorial anticancer chemotherapy in a tumor mouse model. Egypt. J. Exp. Biol. (Zoo.). 2014;
10(1): 41-46.
26. K. Andrijauskaite, S. Suriano, CA Cloud1, M Li, P Kesarwani, LS Stefanik, KM Moxley, Mohamed L
Salem, E Garrett-Mayer, CM Paulos, S Mehrotra, JN Kochenderfer, DJ Cole and MP Rubinstein. IL-12
conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene
Therap, 2015, 18.
27. Mark P. Rubinstein*, Ee Wern Su, Samantha Suriano, Colleen A. Cloud, Kristina M. Schwartz, Katelyn
Williams, C. Bryce Johnson, Mingli Li, Gina M. Scurti, Mohamed L. Salem, Chrystal M. Paulos, Shikhar
Mehrotra, Elizabeth Garrett-Mayer, Michael I. Nishimura, and David J. Cole. IL-12 enhances the
function and anti-tumor activity in murine and human CD8+ T cells. Cancer Immunology and
Immunotherapy. 2015 May;64(5):539-49 IP 3.701
28. *Mohamed L Salem, Shoukry NM, Zidan AA, Vournakis J. Immunomodulatory effects of IL-12
released from poly-N-acetyl glucosamine gel matrix during schistosomiasis infection.
Cytotechnology. 2014, 66(4):667-75. IP 1.207
29. Daz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Mohamed L Salem, Wieder E,
Komanduri K, Montero AJ, Lichtenheld MG. Understanding the biology of ex vivo-expanded CD8 T
cells for adoptive cell therapy: role of CD62L. Immunol Res. 2013, 57(1-3):23-33. IP 3.026
30. Mark P Rubinstein, Mohamed L Salem, Andrew L Doedens, Caitlin J Moore, Cody Chiuzan, Guillermo
L Rivell, David J Cole and Ananda W Goldrath. G-CSF/anti-G-CSF antibody complexes drive the
potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell
Curriculum Vitae
31.
32.
33.
34.
35.
37.
38.
39.
40.
41.
December, 2015
43.
http://www.tanta.edu.eg/en/
Page
42.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
December, 2015
and David J. Cole: Cyclophosphamide induces dynamic alterations in the host microenvironments
resulting in a FLT3L-dependent expansion of dendritic cells. J Immunology 184: 1737-1747, 2010. IP
5.788
* Mohamed L Salem, Sabry A. El-Naggar, David J. Cole: Cyclophosphamide induces bone marrow to
generate high numbers of functional dendritic cells in vitro with adjuvant effects to T cell responses
in vivo. Cell Immunology 2010;261(2):134-143. IP 1.974
* Mohamed L Salem, C. Marcela Daz-Montero, Amir A. AL-Khami, Sabry A. EL Naggar, Osama Naga,
Alberto J. Montero, Ahmed Khafagy, and David J. Cole Recovery from cyclophosphamide-induced
lymphopenia results in expansion of immature dendritic cells which can mediate enhanced primeboost vaccination anti-tumor responses in vivo when stimulated with the TLR3 agonist poly(I:C). J
Immunology, 2009(182)15: 2030-2040. IP 5.788
* Mohamed L Salem, C. Marcela Diaz-Montero, Sabry A. EL-Naggar, Omar Moussa, Yian Chen, and
David J. Cole: The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific
responses upon their adoptive transfer into nave recipient mice. Vaccine, 2009, 27: 549-557. IP
3.766
Mark P Rubinstein, Mohamed L Salem, Andre N Kadima, Christophe L Nguyen, William E Gillanders,
David J Cole. Loss of T cell-mediated antitumor immunity after construct-specific downregulation of
retrovirally encoded T-cell receptor expression in vivo. Cancer Gene Therapy, 2009 Feb;16(2):171183. IP 2.802
Alberto J Montero, Mohamed L Salem, Elizabeth Garrett-Mayer David Cole, Marcela Diaz. Increased
Levels of Circulating Myeloid-Derived Suppressor Cells in Solid Tumor Patients Correlate With
Advanced Clinical Cancer Stage, Increased Tumor Burden, and Cyclophosphamide Containing
Chemotherapy. Cancer Immunology and Immunotherapy. 2009 Jan;58(1):49-59. IP 3.701
Wael Y. Attia, Randa E. EL-Naggar, and Mohamed L Salem. Quantitative and qualititative effects of
eicosapentaenoic acid-28 (EPA-28) treatment on different immune cells of mice. Egypt. J. Exp.
Biology. (Zool), 4:37-46, 2008.
C. Marcela Daz-Montero, Sabry El Naggar, Randa El Naggar, Amir Al Khami, Alberto J Montero.,
David J Cole., and * Mohamed L Salem. Priming of naive cells in the presence of CD62Lhi IL-12
selectively enhances the survival of CD8+ CD62L cells and results in superior anti-tumor activity.
Cancer Immunology & Immunotherapy, 2008 Apr;57(4):563-72. IP 3.701
* Mohamed L Salem, Andre Kadima, Sabry EL-Naggar, and William E. Gillanders, David J. Cole.
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ Tcell response to peptide vaccination: creation of a beneficial host microenvironment involving type I
IFNs and myeloid cells. J Immunotherapy 2007 Jan;30(1):40-53. IP 3.267
* Mohamed L Salem, Provision of cytokines and cytokine-inducing adjuvants along with peptidebased vaccination accentuated intrahepatic retention of antigen-activated CD8+ T cells: opposing
roles for natural killer and Kupffer cells. Egyptian J. Experimental Biology. 2006, 2:33 - 47.
* Mohamed L Salem, Andre Kadima, Sabry EL-Naggar, William E. Gillanders, and David J. Cole. The
adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid (poly I:C) on antigenspecific CD8 T cell responses are partially dependent on NK cells and macrophages with the
induction of a beneficial cytokine milieu. Vaccine. 2006 12(24):5119- 5132. IP 3.766
* Mohamed L Salem, Mohsen Zommara and K. Imaizumi. Dietary supplementation of tiger nut
(Cyperus esculentus L) attenuates inflammatory cell responses in apolipoprotein E knockout mouse.
Amer Journal of Immunology 1 (1): 60-67, 2005.
Narender Nath, Shalinendra Giri, Ratna. Prasad, Mohamed L Salem, Avtar K. Singh, and Inderjit
http://www.tanta.edu.eg/en/
44.
Page
Curriculum Vitae
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
December, 2015
http://www.tanta.edu.eg/en/
56.
Page
Curriculum Vitae
Curriculum Vitae
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
2.403
* Mohamed L Salem, Hossain SM, and Nomoto K. Mediation of the immunomodulatory effects of estradiol on inflammatory responses by inhibition of recruitment and activation of the inflammatory
cells, and their gene expression of TNF-alpha and IFN-gamma International Archives of Allergy and
Immunology 121:235-245, 2000. IP 2.403
* Mohamed L Salem and W. El Shouny. Exopolysaccharides produced by Pseudomonas syringae
pathovars suppress tumor cell proliferation and augment thymocyte proliferation in vitro. Az. J.
Pharm Sci 25: 175-188, 2000.
* Mohamed L Salem and Randa Ez Al Deen Al Nagar. Immunomodulatory and antitumor effects of
simultaneous treatment of mice with n-3 and n-6 polyunsatrated fatty acids. J. Union Arab Biol, Vol.
14A:489-505, 2000.
* Mohamed L Salem and Wael Y Attia. Synergestic effect of -estradiol andprogesterone on the
distribution of the immune cells in the lymphoid tissues. J. Union Arab Biol, Vol 14A:293-307, 2000.
* Mohamed L Salem, Matsuzaki G., Gamal Madkour, and Nomoto K. -estradiol-induced
suppression of macrophages functions in the course of Listeria monocytogenes infection is mediated
by suppression of IL-12 and TNF-alpha expression. Int. J. Immunopharm 21;487-497, 1999. IP 2.376
* Mohamed L Salem. Increase of the bacteriostatic function against early infection of mice with
Listeria monocytogenes after treatment with -estradiol. J. Egypt German Society of Zoology,
Vol.23(A), Comp. Physiol, 347-378, Feb. 1997.
Wael Attia Y., Randa El-Naggar E., Mohamed L Salem, and El-Bolkiny S. Influence of prolactin and
prolactin antagonist, bromocriptine, on the regulation of the immune response. J. Egypt German
Society of Zoology, Vol.23(A), Comp. Physiol., 325-346, Feb. 1997.
El-Bolkiny E Mohamed L Salem, Wael Attia Y., and AL-Sharkawy I. Toxicological study of Ammi majus
as a plant mollusccicide on the hemolysis and hemolysis-related parameters. J. Egypt German
Society of Zoology, Vol.23 (A), Comp. Physiol. 379-3401, Feb. 1997.
* Mohamed L Salem, Wael Attia Y., Wageh Awara A., Al Mehallawy A. Immunotoxicity of cadmium
chloride in mice. J. Union Arab Biology, Vol. 6 (A) Zoology, 531-554, Nov. 1996.
Fouad A. Abou-Zaid; Siham B. Salem and Mohamed L Salem. Oesteology of Psammomys obesus I.
The cranial region. Delta J. Sci. 13 (4): 2087-3002, 1989.
Fouad A. Abou-Zaid; Siham B. Salem and Mohamed L Salem. Oesteology of Psammomys obesus. II.
The post-cranial region. Delta J. Sci. 13 (4): 3003-3024, 1989.
Fouad A. Abou-Zaid; Siham B. Salem and Mohamed L Salem. Histological studies on the digestive
system of the fat sand rat Psammomys obesus. Delta J. Sci. 12 (2): 1141-1166, 1988.
Review Articles
80. *Mohamed L. Salem and Zihai Li, Immune privilege signatures of stem cells. In Preparation.
81. Mohamed L Salem and Ahmed El-Badawy. PD-1/PD-L1 signaling pathway in anti-Hepatitis C virus
immunity: Implications of its blockade in immunotherapy. World Journal of Hepatology, September
2015.
82. *Mohamed L. Salem, Ahmed S. El Badawy, and Zihai Li: Immunobiology and signaling pathways of
cancer stem cells. Cytotechnology, 2015 Oct;67(5):749-759. IP 1.207
83. Alenzi FQ, Mohamed L Salem, Alenazi FA, Wyse RK. Cellular and molecular aspects of goodpasture
syndrome. Iran J Kidney Dis. 2012 Jan;6(1):1- IP 0.87
http://www.tanta.edu.eg/en/
69.
December, 2015
Page
68.
December, 2015
84. Faris Q Alenzi, Mohammed A Alsakran Altamimi, Omar Kujan, Bassel Tarakji, Waleed Tamimi, Omar
Bagader, Ali Al-Shangiti, Abdulrahman B T Alanazi, Awwad K Alenezy, Farhan Al-Swailmi, Dhaifallah
Aleniz, Mohamed L Salem and Richard KH Wyse. Antioxidant Properties of Nigella sativa. Journal of
Molecular and Genetic Medicine. 2013, Vol. 3: 1-5 IP 2.483
85. Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamda, et al,. Defining the Critical
Hurdles in Cancer Immunotherapy. Journal of Translational Medicine 2011, 9:214. This is an
international consortium review article of 105 authors. I am co-author number 83. IP 3.474
86. Mohamed L. Salem: Triggering of toll-like receptor signaling pathways in T cells contributes to the
anti-tumor efficacy of immunotherapy. Immunology Letter; Jun 30;137(1-2):9-14, 2011. IP 2.526
87. Mohamed L Salem, Marina Demcheva, William E. Gillanders, David J Cole and John N. Vournakis.
Poly-N-acetyl glucosamine gel Matrix as a non-viral delivery vector for DNA-based vaccination.
AntiCancer Research. 2010 Oct;30(10):3889-94. IP 1.725
88. * Mohamed L Salem, Maha EL-Demellawy, and Abdel Raouf Abou El-Azm: The potential use of Tolllike receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus. Cellular
Immunology 262 (2010) 96-104. IP 1.974
89. * Mohamed L Salem: The potential use of dendritic cell-based immunotherapy for treatment of
pancreatic cancer. Immunology, Endocrine and Metabolic Agents in Medicinal in Medicinal
Chemistry" (IEMAMC), 2009, Vol. 9(4): 191-202. IP 3.321
90. * Mohamed L Salem and David J. Cole: Dendritic cell recovery post lymphodepletion: A potential
mechanism for anti-cancer adoptive T cell therapy and vaccination. Cancer Immunology and
Immunotherapy. 2010 Mar;59(3):341-353. IP 3.701
91. * Mohamed L Salem, Faris Q. Al-Anzi, Narender Nath, Ali A. Al-Jabri, Jamal Arif, Iman M. El-Nashar,
Iman El-Tounsi, and Richard N. Wyse: Plasticity of T cell differentiation: A double-edged sword for
immune responses. Immunology, Endocrine and Metabolic Agents in Medicinal in Medicinal
Chemistry (IEMAMC), Vol. 9(2): 90-105, 2009. . IP 3.321
92. Faris Q Alenzi, Mohammed W Al-Rabia, Badi Q Alenazi, Abdulla M Mubaraki, Mahmoud Lotfy,
Mohamed L Salem, Haris M Siddiqui, Jamal M Arif, Shamweel Ahmad, Ali A Al-Jabri, Richard K
Wyse. Role of CTLA-4 in xenotransplantation. Pak J Physiol 2009;5(2):40-45.
93. * Mohamed L Salem, Faris Q. Alenzi, Iman M. El-Nashar, Iman EL-Tounsi and Richard N. Wyse:
Teaching versus research dilemma in academia: A literature review. The BioMed Scientist
(www.aabs-inc.org), Vol. 5, 2009: 6-9.
94. Faris Q. AL-Enzi and Mohamed L Salem. The Hematopoietic Stem Cells: Between Apoptosis and Selfrenewal. Yale J. Biology Medicine 2009, 82:7-18.
95. * Mohamed L Salem and David J Cole: TH1/TH2 Cytokine Fingerprinting for Probing Diseases: From
the Bench to the Clinic. Journal of Medical Sciences 2008; 1(2): 61-67.
96. Mohamed L Salem: Bridging scientific enterprise in developed and less developed countries: Ideas
for improving Sciences in developing countries. The BioMed Scientist (www.aabs-inc.org), Vol. 3,
2007: 3-4.
97. Faris Q. AL-Enzi and * Mohamed L Salem. Career preference among university's faculty: Literature
review.
Education
Resources
Information
Center
(ERIC),
2007.
eric.ed.gov/ERICWebPortal/recordDetail?accno=ED497697.
98. *Mohamed L Salem, Andre Kadima, Sabry EL-Naggar, and William E. Gillanders, David J. Cole. Novel
non-viral delivery approaches for IL-12 protein and gene systems: curbing toxicity and enhancing
adjuvant activity. J. Interferon & Cytokine Research, 2006, 26(9): 593-608. IP 3.063
99. *Mohamed L Salem, Immunomodulatory and immunotherapeutic properties of Nigella sativa L.
http://www.tanta.edu.eg/en/
Page
Curriculum Vitae
Curriculum Vitae
December, 2015
Books
109. Mohamed Labib Salem, Ahmed Al-Badawy, Faris Q Alenzi: Fundamental of Cancer Biology.
Under Revision.
http://www.tanta.edu.eg/en/
Page
MS Thesis
Anatomical studies on the rodent of the genus Psammomys found in Egypt deserts.
Tanta University, Faculty of Science, Egypt, September 1989.
Mentor: Late Professor Gamal Abdel Raouf Madkour, PhD, Tanta University, Egypt
10
THESES
Curriculum Vitae
December, 2015
PhD Thesis
Influence of contraceptive hormones on the interrelationship between endocrine and immune systems.
Tanta University, Faculty of Science, Egypt and Kyushu UniversityFukuoka, Japan, December 1995.
Professor Kikuo Nomoto, Medical Institute of Bioregulation, Department of Immunology,
Kyushu University, Japan
Prof. Gamal Abdel Raouf Madkour, PhD, Tanta University, Egypt
Page
11
Related Links
http://orl.tanta.edu.eg/cecr/
http://www.tanta.edu.eg/UNITES/GITTC/word.html
https://tanta.academia.edu/ProfMohamedLabibSalem
https://scholar.google.com.eg/citations?hl=en&user=WTEDAJsAAAAJ&view_op=list_works&sortby=pubd
ate
https://www.researchgate.net/profile/Mohamed_Salem13
http://www.tanta.edu.eg/en/